NEUP
Neuphoria Therapeutics Inc.
NASDAQ · Healthcare · Medical - Pharmaceuticals · US
$3.31
+0.30%Margins
Gross margin
43.5%
EBITDA margin
-1084.7%
EBIT margin
-1187.7%
Net margin
-1578.4%
FCF margin
—
-75.3%
Return on equity
-64.6%
Return on assets
-56.6%
Return on invested capital
0.04x
Asset turnover
-$12.4B
Cash from operations
$3.67
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026